X4 Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $560 | $563 | $0 | $3,060 |
Gross Profit | 333 | 295 | -62 | 2,998 |
EBITDA | -34,000 | -33,703 | -49,811 | -17,149 |
EBIT | -34,267 | -33,897 | -49,873 | -17,211 |
Net Income | -36,696 | 90,833 | -51,766 | -19,130 |
Net Change In Cash | 560 | 563 | 0 | 3,060 |
Free Cash Flow | -34,124 | -30,411 | -33,656 | -27,782 |
Cash | 97,412 | 147,218 | 60,493 | 99,466 |
Basic Shares | 200,865 | 200,801 | 199,991 | 198,766 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,000 |
Gross Profit | -1,996 | -1,994 | -1,892 | 3,000 |
EBITDA | -107,522 | -87,569 | -85,107 | -59,523 |
EBIT | -107,941 | -89,563 | -86,999 | -59,874 |
Net Income | -101,167 | -93,867 | -88,696 | -62,131 |
Net Change In Cash | 0 | 0 | 0 | 3,000 |
Cost of Revenue | 40,025 | -47,786 | ||
Free Cash Flow | -96,572 | -77,205 | -71,520 | -60,180 |
Cash | 99,216 | 121,718 | 81,787 | 78,708 |
Basic Shares | 177,812 | 63,526 | 25,749 | 20,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.26 |
2023-12-31 | -$0.10 |
